Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07640893 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in patients with von Willebrand disease.
Trial Details
NCT Number NCT07640893
Lead Sponsor Shanghai RAAS Blood Products Co., Ltd.
Conditions
(from sponsor)		 Von Willebrand Disease (VWD)
Related terms von Willebrand Diseases
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov